Urothelial
Study Name: FUJIFILM(FF10832-PEM-201)
- Cancer Stage: IV
- Key Inclusion: Progressive disease during/within 12 weeks of treatment with PD-(L)1 inhibitor
- Description: A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
- Study Number: FF-10832
- NCT#: NCT05318573